Hematology/Oncology — Medicare Part B billing by state
189 physician groups whose primary specialty is Hematology/Oncology billed $1.56B to Medicare fee-for-service in 2024.
Calendar year 2024 · Medicare fee-for-service Part B
| State | Groups | Services | Beneficiary-episodes | Medicare payments | Standardized payments ↓ | Payments / group | Services / group |
|---|---|---|---|---|---|---|---|
| Florida | 21 | 32,488,484 | 1,767,402 | $403,365,749 | $402,715,110 | $19,207,893 | 1,547,071 |
| California | 35 | 10,820,268 | 413,910 | $166,600,340 | $159,402,983 | $4,760,010 | 309,151 |
| Arkansas | 3 | 5,091,621 | 301,388 | $80,108,309 | $81,824,000 | $26,702,770 | 1,697,207 |
| Maryland | 7 | 5,540,097 | 203,467 | $79,614,065 | $78,210,850 | $11,373,438 | 791,442 |
| New Jersey | 12 | 5,540,503 | 229,942 | $77,463,209 | $74,108,143 | $6,455,267 | 461,709 |
| Kansas | 1 | 4,325,855 | 91,508 | $68,291,533 | $68,501,955 | $68,291,533 | 4,325,855 |
| Virginia | 11 | 3,252,476 | 182,628 | $66,689,991 | $66,396,412 | $6,062,726 | 295,680 |
| Pennsylvania | 15 | 4,056,590 | 148,967 | $66,534,068 | $65,967,290 | $4,435,605 | 270,439 |
| Tennessee | 6 | 3,877,956 | 280,078 | $64,115,264 | $65,832,574 | $10,685,877 | 646,326 |
| Illinois | 17 | 5,125,226 | 198,645 | $64,044,177 | $64,051,361 | $3,767,305 | 301,484 |
| Arizona | 5 | 3,566,990 | 107,991 | $47,201,370 | $47,664,802 | $9,440,274 | 713,398 |
| Texas | 17 | 3,270,132 | 117,943 | $45,507,591 | $45,939,287 | $2,676,917 | 192,361 |
| South Carolina | 5 | 2,972,280 | 115,696 | $42,722,980 | $42,926,751 | $8,544,596 | 594,456 |
| Mississippi | 4 | 1,786,466 | 68,427 | $34,586,305 | $35,641,210 | $8,646,576 | 446,616 |
| Georgia | 10 | 2,307,653 | 119,090 | $32,257,124 | $32,613,182 | $3,225,712 | 230,765 |
| North Carolina | 8 | 2,012,378 | 95,829 | $28,809,193 | $29,034,540 | $3,601,149 | 251,547 |
| Ohio | 11 | 2,051,033 | 69,948 | $22,435,791 | $22,621,185 | $2,039,617 | 186,458 |
| Indiana | 4 | 1,453,376 | 67,981 | $21,034,474 | $21,338,210 | $5,258,619 | 363,344 |
| Nevada | 5 | 995,087 | 47,801 | $19,612,209 | $19,745,637 | $3,922,442 | 199,017 |
| Delaware | 1 | 587,683 | 17,155 | $16,489,324 | $16,382,302 | $16,489,324 | 587,683 |
| Maine | 1 | 955,804 | 33,087 | $13,536,376 | $13,498,181 | $13,536,376 | 955,804 |
| Louisiana | 6 | 487,989 | 33,725 | $10,580,999 | $11,087,413 | $1,763,500 | 81,332 |
| Michigan | 8 | 678,980 | 53,317 | $10,756,632 | $10,882,310 | $1,344,579 | 84,872 |
| Washington | 3 | 959,370 | 42,530 | $10,600,867 | $10,587,646 | $3,533,622 | 319,790 |
| Missouri | 10 | 357,470 | 41,087 | $9,614,054 | $9,778,809 | $961,405 | 35,747 |
| New Mexico | 3 | 467,806 | 43,191 | $7,285,575 | $7,339,030 | $2,428,525 | 155,935 |
| Nebraska | 1 | 432,345 | 6,663 | $5,854,846 | $5,850,661 | $5,854,846 | 432,345 |
| Alaska | 2 | 256,421 | 11,088 | $5,281,957 | $5,029,880 | $2,640,978 | 128,210 |
| New York | 10 | 499,654 | 32,735 | $5,420,544 | $4,937,457 | $542,054 | 49,965 |
| Alabama | 2 | 129,564 | 2,928 | $4,188,215 | $4,294,102 | $2,094,107 | 64,782 |
| Minnesota | 1 | 299,158 | 5,862 | $4,292,395 | $4,291,708 | $4,292,395 | 299,158 |
| Connecticut | 4 | 545,120 | 13,490 | $4,372,598 | $4,177,408 | $1,093,149 | 136,280 |
| Vermont | 2 | 243,959 | 7,497 | $4,098,402 | $4,055,101 | $2,049,201 | 121,980 |
| Massachusetts | 5 | 286,012 | 11,511 | $3,664,602 | $3,586,923 | $732,920 | 57,202 |
| Iowa | 2 | 195,089 | 6,035 | $3,087,795 | $3,133,590 | $1,543,898 | 97,544 |
| Oregon | 3 | 231,295 | 4,557 | $2,747,305 | $2,696,020 | $915,768 | 77,098 |
| South Dakota | 1 | 83,299 | 1,592 | $1,576,414 | $1,573,690 | $1,576,414 | 83,299 |
| PR | 8 | 65,623 | 5,234 | $1,438,252 | $1,466,168 | $179,782 | 8,203 |
| XX | 1 | 68,827 | 3,535 | $1,401,626 | $1,408,369 | $1,401,626 | 68,827 |
| Kentucky | 2 | 55,648 | 1,915 | $763,065 | $783,987 | $381,533 | 27,824 |
| New Hampshire | 1 | 163,511 | 1,965 | $801,370 | $764,974 | $801,370 | 163,511 |
| Oklahoma | 3 | 9,820 | 5,877 | $533,973 | $568,011 | $177,991 | 3,273 |
| Wisconsin | 3 | 7,920 | 3,038 | $354,382 | $374,799 | $118,127 | 2,640 |
| District of Columbia | 2 | 1,528 | 611 | $110,302 | $101,420 | $55,151 | 764 |
| VI | 1 | 1,450 | 559 | $98,858 | $99,550 | $98,858 | 1,450 |
| Utah | 1 | 1,017 | 342 | $35,367 | $35,776 | $35,367 | 1,017 |
| Colorado | 2 | 187 | 143 | $13,964 | $14,522 | $6,982 | 94 |
| Rhode Island | 1 | 59 | 47 | $4,774 | $4,241 | $4,774 | 59 |
Need this specialty's market in one document?
Notify me at launchEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2024
| Code | Services | Medicare payments ↓ | Largest state markets |
|---|---|---|---|
| J9271 · Injection, pembrolizumab, 1 mg | 9,526,504 | $422,139,574 | FLCAARMDNJ |
| J0897 · Injection, denosumab, 1 mg | 6,237,333 | $127,209,663 | FLCAARMDNJ |
| J9144 · Injection, daratumumab, 10 mg and hyaluronidase-fihj | 2,926,740 | $114,158,670 | FLCAARMDNJ |
| 99214 · Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 1,010,968 | $93,292,134 | FLCAARMDNJ |
| J9299 · Injection, nivolumab, 1 mg | 3,024,549 | $74,081,289 | FLCAARMDNJ |
| 96413 · Administration of chemotherapy into vein, 1 hour or less | 371,238 | $36,735,135 | FLCAARMDNJ |
| 99215 · Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 264,178 | $34,826,519 | FLCAARMDNJ |
| 78815 · Nuclear medicine study from skull base to mid-thigh with ct scan | 27,195 | $32,856,563 | FLCAARMDNJ |
| J1569 · Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 911,263 | $32,406,652 | FLCAARMDNJ |
| J1437 · Injection, ferric derisomaltose, 10 mg | 2,012,512 | $31,709,410 | FLCAARMDNJ |
| J0881 · Injection, darbepoetin alfa, 1 microgram (non-esrd use) top by services | 8,356,846 | $19,301,481 | FLCAARMDNJ |
| J1439 · Injection, ferric carboxymaltose, 1 mg top by services | 13,849,137 | $12,014,941 | FLCAARMDNJ |
| J0185 · Injection, aprepitant, 1 mg top by services | 3,681,492 | $4,909,278 | FLCAARMDNJ |
| Q0138 · Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) top by services | 10,486,001 | $2,876,723 | FLCAARMDNJ |
| Q5110 · Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram top by services | 3,319,322 | $716,469 | FLCAARMDNJ |
| Q9967 · Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml top by services | 2,938,937 | $297,538 | FLCAARMDNJ |
Every code above is searchable free at full depth. Ranking organizations across several codes at once — one combined market view — is part of a Nevvi subscription.
Notify me at launch